发明名称 |
Process for preparating ivabradine hydrochloride form IV and methods of treatment of disease using ivabradine hydrochloride form IV |
摘要 |
Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing Ivabradine hydrochloride Form IV. |
申请公布号 |
US9309201(B2) |
申请公布日期 |
2016.04.12 |
申请号 |
US201514806224 |
申请日期 |
2015.07.22 |
申请人 |
URQUIMA, S.A. |
发明人 |
Prohens Lopez Rafael;Puigjaner Vallet Cristina;Barbas Canero Rafael;Del Rio Pericacho Jose Luis;Marti Via Josep |
分类号 |
C07D223/16;A61K9/28;A61K9/20;A61K31/55 |
主分类号 |
C07D223/16 |
代理机构 |
The Roy Gross Law Firm, LLC |
代理人 |
The Roy Gross Law Firm, LLC ;Gross Roy |
主权项 |
1. A process for preparing ivabradine hydrochloride Form IV with a powder X-ray diffraction comprising the following degrees 2 theta (±0.2) peaks: 8.74, 15.55, 17.17, 19.89, and 24.29, wherein the X-ray diffraction is measured using a CuKα radiation, the process comprising:
a) slurrying ivabradine hydrochloride in a solvent system comprising toluene, ethanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, ethyl acetate, isopropyl acetate and mixtures thereof; wherein said step of slurrying ivabradine occurs at a temperature of lower than 60° C. and the reaction time for said step of slurrying ivabradine is less than 48 h; and b) isolating the ivabradine hydrochloride Form IV. |
地址 |
Barcelona ES |